🚀 Pharmidex Unveils Its Cutting-Edge In Silico Drug Discovery Platform! 🧬💻
February 24, 2025

At Pharmidex, we are revolutionizing drug discovery with our state-of-the-art in silico platform (https://lnkd.in/eibfwguP), accelerating the path from target identification to lead optimization with precision and efficiency.

🔬 What sets our platform apart?
✅ AI-driven target identification & protein structure analysis
✅ Advanced molecular docking for high-affinity ligand screening
✅ 3D pharmacophore modeling for enhanced drug design
✅ Seamless integration of predictive simulations & real-world validation

Our approach combines cutting-edge computational tools with deep scientific expertise to de-risk drug development and fast-track novel therapeutics for a healthier future.

📽️ Watch our latest video(1/5) showcasing the power of our technology, starting from Determination of target structures and Determination of ligands

📩 Ready to transform your drug discovery journey? Let’s collaborate!

LC-MS bioanalysis At Pharmidex

February 4, 2026
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis

🔬 Clinical Chemistry Services at Pharmidex

February 2, 2026
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry

BIA Annual Gala Dinner

January 29, 2026
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
More Posts